In the present study, the relevance of TLR4 SNPs, Asp299Gly (rs4986790) and Thr399Ile (rs4986791) are investigated in 105 ovarian cancer patients retrospectively with an extended follow-up and complete representative adjuvant therapy (chemotherapy with or without surgical treatment). The gene discussed is TLR4; the disease is ovarian carcinoma.